Is drug facilitated sexual assault changing? About a case involving 4-bromomethcathinone
Journal of Analytical Toxicology · 04.06.2026 · 50 (6)
DOI: 10.1093/jat/bkag058 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Analytical Toxicology, online erschienen am 01.07.2026. Verfasst von Thomas Schiestel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Toxicologie Biologique, Fédération de Toxicologie, Hôpital Lariboisière, APHP, Paris, 75010, France. Hauptthemen laut MEDLINE: Substance Abuse Detection, Sex Offenses, Psychotropic Drugs, Rape. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Drug-facilitating sexual assault (DFSA) corresponds to sexual activity occurring whereas the victim is unable to express consent due to the action of drugs. Although the use of sedative and amnesic drug in DFSA, such as benzodiazepines and gamma-hydroxybutyrate, is widely described in the medical literature, there is a lack of information regarding the involvement of amphetamine derivatives in this context, particularly synthetic cathinones. Herein, we report a case of a 19-year-old woman who presents herself to the emergency department following an acute alcoholic intoxication and a suspected DFSA after going to a nightclub. The emergency toxicological screening on the plasma and urine of the patient, performed through liquid chromatography coupled to high resolution tandem mass spectrometry in target and non-target mode and with gas chromatography coupled to high resolution mass spectrometry, enabled the detection of 4-bromomethcathinone, a new psychoactive substance (NPS) of the cathinone family. The demethylated and reduced metabolites of the drug were also found in both plasma and urine. No other substance was identified except ethanol, which was quantified in gas chromatography–flame ionization detection, and diazepam with its metabolites, this last one having been administrated in the emergency department. As far as we know, this report described the first case of DFSA involving this halogenated derivative of cathinone and consequently, highlights the need for toxicologists to systematically investigate with specific analytical methods the potential presence of NPS in cases of DFSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratoire de Toxicologie Biologique, Fédération de Toxicologie, Hôpital Lariboisière, APHP, Paris, 75010, France.
- INSERM UMRS-1144, Université Paris Cité, 4 avenue de l'Observatoire, Paris, 75006, France.
- Service d'Urgences-SMUR, Hôpital Lariboisière, APHP, Paris, 75010, France.
- Centre Antipoison, Fédération de Toxicologie, Hôpital Fernand Widal, APHP, Paris, 75010, France.
ORCID-Profile: Thomas Schiestel, Pascal Houzé
Zitieren
APA
Schiestel, T., Magny, R., Minka, H. F., Langrand, J., Houzé, P., & Labat, L. (2026). Is drug facilitated sexual assault changing? About a case involving 4-bromomethcathinone. Journal of Analytical Toxicology, 50(6). https://doi.org/10.1093/jat/bkag058
Vancouver
Schiestel T, Magny R, Minka HF, Langrand J, Houzé P, Labat L. Is drug facilitated sexual assault changing? About a case involving 4-bromomethcathinone. Journal of Analytical Toxicology. 2026;50(6). doi:10.1093/jat/bkag058
BibTeX
@article{Schiestel2026,
author = {Schiestel, Thomas and Magny, Romain and Minka, Hilary Fadi and Langrand, Jérôme and Houzé, Pascal and Labat, Laurence},
title = {Is drug facilitated sexual assault changing? About a case involving 4-bromomethcathinone},
journal = {Journal of Analytical Toxicology},
year = {2026},
volume = {50},
number = {6},
doi = {10.1093/jat/bkag058}
}
EUVIMED